Skip to content
About Us
Company Overview
Leadership Team
Board of Directors
Medical Advisory Board
Contact Us
Careers
Patients & Families
Gene Therapies
Our Approach
Publications & Presentations
Pipeline & Programs
Pipeline
Inherited Retinal Disease (IRD) Programs
Partnered Programs
Investors
Opus Genetics
Presentation
Development of OPGx-BEST1 AAV gene therapy for the treatment of bestrophinopathies
